← Browse by Condition
Medical Condition

complication

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for complication sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — complication Clinical Trials

How many clinical trials are currently recruiting for complication?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for complication, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for complication?
complication research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a complication clinical trial?
Eligibility criteria for complication trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Centre Leon Berard 1 trial
Beijing Tiantan Hospital 1 trial
Hospital de Alta Complejidad en Red 1 trial

Recruiting Clinical Trials

NCT05947136
Recruiting
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
Enrollment
204 pts
Location
France
Sponsor
Centre Leon Berard
View Trial →
NCT04362709
Recruiting
Study of Post-anesthesia Management in Patients Undergoing Neurosurgery
Enrollment
10,000 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT07233304
Recruiting
Complications of the Alveolar Opening Maneuver in Children on Mechanical Ventilation
Enrollment
143 pts
Location
Argentina
Sponsor
Hospital de Alta Complejidad e...
View Trial →

Related Conditions

multiple myeloma (1) anesthesia (1) neurosurgery (1) positive end expiratory pressure peep (1) oxygenation index (1) pediatric intensive care unit (1) pediatric acute lung injury (1) respiratory distress syndrome pediatric (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology